- Home
- UBCP vs AGEN Comparison
UBCP vs AGEN Comparison
Compare UBCP & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBCP
- AGEN
- Stock Information
- Founded
- UBCP 1902
- AGEN 1994
- Country
- UBCP United States
- AGEN United States
- Employees
- UBCP N/A
- AGEN N/A
- Industry
- UBCP Major Banks
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UBCP Finance
- AGEN Health Care
- Exchange
- UBCP Nasdaq
- AGEN Nasdaq
- Market Cap
- UBCP 76.2M
- AGEN 87.7M
- IPO Year
- UBCP N/A
- AGEN 2000
- Fundamental
- Price
- UBCP $14.65
- AGEN $5.51
- Analyst Decision
- UBCP
- AGEN Buy
- Analyst Count
- UBCP 0
- AGEN 4
- Target Price
- UBCP N/A
- AGEN $13.00
- AVG Volume (30 Days)
- UBCP 8.5K
- AGEN 1.3M
- Earning Date
- UBCP 08-06-2025
- AGEN 08-07-2025
- Dividend Yield
- UBCP 6.27%
- AGEN N/A
- EPS Growth
- UBCP N/A
- AGEN N/A
- EPS
- UBCP 1.24
- AGEN N/A
- Revenue
- UBCP $29,412,000.00
- AGEN $99,524,000.00
- Revenue This Year
- UBCP N/A
- AGEN $12.69
- Revenue Next Year
- UBCP $5.59
- AGEN N/A
- P/E Ratio
- UBCP $11.76
- AGEN N/A
- Revenue Growth
- UBCP N/A
- AGEN N/A
- 52 Week Low
- UBCP $11.40
- AGEN $1.38
- 52 Week High
- UBCP $15.64
- AGEN $18.74
- Technical
- Relative Strength Index (RSI)
- UBCP 62.86
- AGEN 62.45
- Support Level
- UBCP $13.31
- AGEN $4.34
- Resistance Level
- UBCP $15.64
- AGEN $5.22
- Average True Range (ATR)
- UBCP 0.59
- AGEN 0.43
- MACD
- UBCP 0.08
- AGEN -0.05
- Stochastic Oscillator
- UBCP 60.24
- AGEN 92.86
About UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).